Assignee
BEIJING SHENOGEN PHARMA GROUP LTD
CN·4 granted patents·1 pending application·1 citations·filing 2012–2020
Top patents by PatentIndex Score
5 records- 0158US9301942B2Use of icaritin for the preparation of composition for treating cancerBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2014·Granted Apr 5, 2016·1 cites·4 claims
- 0249US12209074B2SHP2 phosphatase allosteric inhibitorBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2020·Granted Jan 28, 2025·0 cites·8 claims
- 0349US2022249370A1Nano-micelle preparation of icaritin and preparation method therefor and application thereofBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2020·Application pending·0 cites
- 0447US10233249B2Antibodies and methods for treating estrogen receptor-associated diseasesBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2014·Granted Mar 19, 2019·0 cites·14 claims
- 0538US9221781B2Synthesis of polyhydroxy chromenone compounds and their anti-tumor effectsBEIJING SHENOGEN PHARMA GROUP LTD·Filed 2012·Granted Dec 29, 2015·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when BEIJING SHENOGEN PHARMA GROUP LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →